Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

7.7K
Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
7.7K
Viral Mutations00:36

Viral Mutations

36.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
36.9K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

58
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
58
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

301
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
301
Position-effect Variegation02:32

Position-effect Variegation

6.7K
In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
6.7K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

172
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
172

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antagonism of stress granules key for SARS-CoV-2 infection and pathogenesis.

bioRxiv : the preprint server for biology·2026
Same author

Key residues in SARS-CoV-2 NSP3 hypervariable region are necessary to modulate early stress granule activity.

Journal of virology·2026
Same author

mRNA-delivered neutralizing antibodies confer protection against SARS-CoV-2 in animal models.

Journal of virology·2026
Same author

Key residues in SARS-CoV-2 NSP3 hyper variable region are necessary to modulate early stress granule activity.

bioRxiv : the preprint server for biology·2025
Same author

Genomic characterization of arboviruses discovered between the 1950s and 1980s.

Journal of virology·2025
Same author

A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID-19-Flu Mucosal Vaccines.

Small science·2025

Related Experiment Video

Updated: Nov 10, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

The variant gambit: COVID-19's next move.

Jessica A Plante1, Brooke M Mitchell1, Kenneth S Plante1

  • 1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA.

Cell Host & Microbe
|March 31, 2021
PubMed
Summary

New SARS-CoV-2 variants, including those from the UK and Brazil, raise concerns for increased spread and immune escape. Understanding variant evolution and mutations is crucial for managing the ongoing COVID-19 pandemic.

Keywords:
2019-nCoVCOVID-19SARS-CoV-2coronavirusfurin cleavagespike

More Related Videos

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.5K
Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
18:10

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency

Published on: June 16, 2011

29.8K

Related Experiment Videos

Last Updated: Nov 10, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
06:08

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

Published on: September 8, 2023

1.5K
Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency
18:10

Isolation of Fidelity Variants of RNA Viruses and Characterization of Virus Mutation Frequency

Published on: June 16, 2011

29.8K

Area of Science:

  • Virology
  • Epidemiology
  • Genetics

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, continues globally despite vaccine development.
  • Emergence of significant SARS-CoV-2 variants (e.g., B.1.1.7, B.1.351, P.1, B.1.429) from various locations poses new challenges.
  • Concerns include increased transmissibility, potential for vaccine and natural immunity escape, and further mutations, including a mink strain.

Purpose of the Study:

  • To outline factors driving the evolution of SARS-CoV-2 variants.
  • To explore the impact of specific mutations on viral characteristics.
  • To examine the risk of future mutations and identify necessary experimental studies.

Main Methods:

  • Review of scientific literature on SARS-CoV-2 variants.
  • Analysis of mutations in spike and non-spike proteins.
  • Discussion of experimental approaches to assess variant threats.

Main Results:

  • Identified key SARS-CoV-2 variants and their geographical origins (UK, South Africa, Brazil, California).
  • Examined mutations within and outside the spike protein, which are critical for viral function.
  • Highlighted the potential for variants to increase spread and evade immune responses.

Conclusions:

  • SARS-CoV-2 variant evolution is driven by specific factors, necessitating ongoing surveillance.
  • Understanding mutations is key to predicting variant behavior and impact on public health.
  • Further experimental studies are essential to fully assess the threat posed by SARS-CoV-2 variants and inform vaccine efficacy strategies.